The FDA Has Approved TRELSTAR(R) 22.5 mg, The First 6-Month GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer

Watson Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Trelstar – 22.5 mg (triptorelin pamoate for injectable suspension) at a dosage which will be required only to be administered twice a year. […]

Death Due to Competing Risks in Men with Metastatic Prostate Cancer

The old adage, prostate cancer is the cancer that you die with not the cancer you die from has been around for a long time. No question compared too many other cancers prostate cancer does progress more slowly than many other cancers. But, is this adage true? Men with prostate cancer have competing mortality risks [...]

Ron Gerhard Speaks About the American Cancer Society & PSA Testing

There has been a lot of criticism about the recent guidelines on PSA testing that has been issued by the American Cancer Society (ACS). Many of us with advanced prostate cancer are appalled with these guidelines and feel it is just another example of the ACS abandoning men with cancer over the powerful breast cancer [...]

NO ONE DESERVES CANCER!

I don’t know if you have ever thought about it, but sometimes I think about who gets cancer and who doesn’t. It is hard not to think about this after having three different cancers. According to scientists, we know of some things that can cause cancer, such as certain environmental exposures. Exposure only means that [...]

Go to Top